Ascent Group LLC Has $740,000 Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)

Ascent Group LLC reduced its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 5.7% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 5,081 shares of the financial services provider’s stock after selling 308 shares during the quarter. Ascent Group LLC’s holdings in iShares Biotechnology ETF were worth $740,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently added to or reduced their stakes in IBB. BNP Paribas Financial Markets grew its stake in shares of iShares Biotechnology ETF by 29.3% during the third quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock worth $346,561,000 after purchasing an additional 538,899 shares during the period. Healthcare of Ontario Pension Plan Trust Fund grew its position in shares of iShares Biotechnology ETF by 32.9% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock worth $96,533,000 after buying an additional 164,000 shares during the period. State of Michigan Retirement System increased its stake in shares of iShares Biotechnology ETF by 150.0% in the 2nd quarter. State of Michigan Retirement System now owns 125,000 shares of the financial services provider’s stock valued at $17,158,000 after acquiring an additional 75,000 shares during the last quarter. Aristides Capital LLC acquired a new stake in shares of iShares Biotechnology ETF in the 2nd quarter valued at approximately $9,180,000. Finally, Sanctuary Advisors LLC bought a new position in iShares Biotechnology ETF during the 2nd quarter worth approximately $8,118,000. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Down 1.2 %

Shares of NASDAQ:IBB opened at $140.00 on Wednesday. The company has a 50 day moving average price of $142.63 and a two-hundred day moving average price of $142.12. iShares Biotechnology ETF has a 52 week low of $121.84 and a 52 week high of $150.57.

iShares Biotechnology ETF Announces Dividend

The firm also recently disclosed a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were paid a dividend of $0.2005 per share. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.